European AIDS Vaccine Trials An advocacy agenda Marion Zibelli EATG’s Vaccine Working Group

Slides:



Advertisements
Similar presentations
EuroPa - Establishment of an European Network of Excellence Müller, M.(1), Neumann, H.(2), Jungraithmeier, T., Almann, F. J., Wagner, M., Smith, S. (1)
Advertisements

Clinical Trials on Trial The Patient Perspective Wim Vandevelde European AIDS Treatment Group (EATG) HAI Europe Open Seminar - November 21st Berlin.
Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.
The European Union THE EUROPEAN UNION How do individuals, businesses and economies benefit from using the Euro?
National Working Group on Microbicides Microbicides advocacy Paramita Kundu & Ananthy Thambinayagam Global Campaign for Microbicides, PATH January 2007.
Patricia de Suzzoni, Chair of ERGEG Customer Working Group Citizens’ Energy Forum, London, September 2009 Regulatory aspects of smart metering in.
22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.
The PACITA Project Dr. Pierre Delvenne, Chargé de recherches FNRS University of Liège, SPIRAL Research Centre Liège, Salle des Professeurs, 25 June 2012.
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
When was the European Union formed? About fifty years ago in Where was the European Union? Belgium, France, Germany, Italy, Luxembourg, and The.
TRANSCAN ERA-NET on translational Cancer Research Application for funds TRANSCAN ERA-NET on translational Cancer Research Aims:  Impact of the health.
The G8 & R&D for neglected diseases Stewart Tyson DFID.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
Established in late 1999 Scientific/clinical resources Ethics committees Regulatory body TT
International AIDS Vaccine Initiative UK CAB May 21, 2004 Maite Suárez, European Country Programmes Officer.
Countries of Europe France Spain Italy Germany Which country is this?
European Business Register Congress of the Notaries of Europe, Brussels, 28 June 2011.
European County Research Project. Task Your job is to research a country from Europe. Your job is to research a country from Europe. You will be exploring.
History of French language Prepared by : Nour YoussefClass:751.
Global Campaign Europe: Making it better, stronger and more strategic Rebekah Webb, Coordinator Global Campaign for Microbicides.
International Partnership for Microbicides Tessa Mattholie, European Liaison Officer, Brussels.
THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.
Jeremy Hurst, Employment and Social Affairs Directorate, OECD, and Luigi Siciliani, University of York European Health Forum Gastein, 6-9 October 2004.
The AIDS Vaccine Policy Agenda Holly J. Wong Vice President, Public Policy International AIDS Vaccine Initiative (IAVI) Vienna, Austria International AIDS.
Microbicides Advocacy at the EU level Rebekah Webb European Coordinator, GCM.
Political Map of Europe Western European Countries.
Meeting the New Challenges for the Single Market Juan Delgado 29 November 2007.
Retirement in Europe Annika Sundén Presentation at 16th Annual Meeting of the Retirement Research Consortium “Social Security and the Retirement Income.
HIV/AIDS and Disability The need for advocacy Jessica de Ruijter August
I will: Know how and why the EU was created. Understand the benefits of being part of the EU.
THE EUROPEAN UNION Italian 2.
History of HUNGARY. Coat of arms of Hungary ( )
E u r o g u i d a n c e A Network of National Resource and Information Centres for Guidance Established in 1992.
The Schengen Agreement And its implications on tourism.
The story of European Union In 1945 the second world war ended.
 Drug Pricing and the Impact on Treatment Access - International Wim Vandevelde - European AIDS Treatment Group (EATG) 2010 HIV Research Catalyst Forum.
European Union (EU) Post WWII Europe. EU (What they are about). Increasing economic and political cooperation. Created 1993 (origins to 1950s) Wanted.
Someone needed here to point out where Europe is….
3 rd WG F meeting: CRUE ERA-Net update Andreas Pichler CRUE ERA-Net dissemination officer.
Chief Financial Officers List
Maps of Topic 2B Multilingualism in Europe Europe A Story of Empire (a united Europe) & Language.
Monitoring of Pharmaceutical Supply in Countries of Eastern Europe, Central Asia and Caucasus Anna Żakowicz European AIDS Treatment Group Presented at.
The European Union Objectives Identify countries within the EU Explain the political and economic structure of the EU What is the importance of.
European Union. Europe is one of the world’s seven continents. The others are Africa North and South America, Antarctica, Asia and Australia.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
European-Comparative Effectiveness Research on online Depression Treatment E-COMPARED is funded by the European Community’s Seventh Framework.
What is the EU? A group of 25 European countries whose governments work together. Aims to change and improve the way people live and do business in Europe.
An overview of activities to engage Eastern Europe and Central-Asia
Chlamydia control in Europe
The European Union (EU for short)
The European Parliament – voice of the people
The European Parliament – voice of the people
Migration and infectious diseases
THE EUROPEAN UNION How do individuals, businesses and economies benefit from using the Euro?
4.8% 6.9 MILLION OLIVE OIL Evolution 2016 versus 2015 PRICE INCREASE
European Citizenship ERASMUS+ "YOGIES" Survey
EU: First- & Second-Generation Immigrants
EUROPEAN UNION the “EU”
THE EUROPEAN UNION How do individuals, businesses and economies benefit from using the Euro?
EUROPEAN UNION the “EU”
European Union Membership
Chapter 8: International Groupings History of the EU: Timeline
European representation of respiratory critical care HERMES participants. European representation of respiratory critical care HERMES participants. Countries.
HEALTH EQUITY EUROPE JOINT ACTION
Someone needed here to point out where Europe is…
HIV infections newly diagnosed in injecting drug users and men who have sex with men, by country, and year of report, 2002– Injecting drug users.
Prodcom Statistics in Focus
Presentation transcript:

European AIDS Vaccine Trials An advocacy agenda Marion Zibelli EATG’s Vaccine Working Group

Or, * Voulez-vous vous joindre aux défenseurs des vaccins contre le sida, ce soir ? * Do you want to join AIDS vaccine advocates tonight?

Once upon a time... Katy De Clercq, Belgium Maxime Journiac, France Simone Marcotullio, Italy Vlastimil Mayer, Slovak Republic Julian Meldrum, UK Jo Robinson, UK Maite Suárez, The Netherlands Joan Tallada, Spain Emmanuel Trénado, France Filippo von Schloesser, Italy Matthias Wienold, Germany Marion Zibelli, Spain (Chair)

...and we are also European AIDS vaccine advocates. We are all European HIV treatment activists...

We believe in the benefit and the necessity to join advocacy on HIV/AIDS treatments and new HIV preventive technologies, such as vaccines. Some will say we live in sin! We don’t believe so.

So let’s unite!  But why?  But how?  And when?

So let’s unite!  But why?  But how?  And when?

The world needs that access to HIV drugs and the best SOC be offered to people who urgently need them. The world needs an AIDS vaccine. –Europe needs an AIDS vaccine.  Scaling-up access to treatment  Enhancing capacity for vaccine trials

So let’s unite!  But why?  But how?  And when?

HIV treatment activists and AIDS vaccine advocates in Europe: Common agendas 1. Inform and educate oCommunity oCivil society oPolicy makers oMPs oMedias 2. Lobby oGovernements oMPs oPolicy makers Both at country, EU and international level.

And many more issues in common... Science and clinical trials Equity Pricing Patents Regulatory aspects Manufacturing Delivery National Plans CABs

Money, money, money With few resources available, what should be our priority? Wait a second... “It’s not either, or. It’s more!” Frans van den Boom, IAVI Europe

So let’s unite!  But why?  But how?  And when? Ce soir?

Let’s continue the discussion... Thank you.